Arrowstreet Capital’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.5K Buy
+18,400
New +$91.2K ﹤0.01% 1804
2025
Q2
Sell
-50,404
Closed -$128K 2012
2025
Q1
$128K Buy
+50,404
New +$187K ﹤0.01% 1756
2021
Q1
Sell
-100,918
Closed -$608K 2384
2020
Q4
$608K Sell
100,918
-61,349
-38% -$343K ﹤0.01% 1966
2020
Q3
$1.17M Buy
162,267
+38,400
+31% +$341K ﹤0.01% 1770
2020
Q2
$1.11M Buy
123,867
+30,778
+33% +$311K ﹤0.01% 1728
2020
Q1
$698K Buy
93,089
+60,809
+188% +$409K ﹤0.01% 1433
2019
Q4
$211K Buy
+32,280
New +$157K ﹤0.01% 1616

Other funds holding KRMD

Arrowstreet Capital's KRMD Position: Q1 2026 in Review

Arrowstreet Capital opened a new position in KORU Medical Systems (KRMD) in Q1 2026: 18,400 shares worth $79.5K. The stake represents ﹤0.01% of the portfolio and ranks #1804 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in KRMD as recently as Q1 2025.

Arrowstreet Capital first reported a position in KRMD in Q4 2019 and has held it in 7 quarters since. The position peaked at $1.17M in Q3 2020. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • Arrowstreet Capital held 18,400 shares of KORU Medical Systems worth $79.5K as of Q1 2026.
  • KORU Medical Systems was a new Arrowstreet Capital position in Q1 2026.
  • KORU Medical Systems made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1804 holding.
  • Arrowstreet Capital first reported a position in KORU Medical Systems in Q4 2019 and has held it in 7 quarters since.
  • Arrowstreet Capital's KORU Medical Systems position peaked at $1.17M in Q3 2020.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.